{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:14:37Z","timestamp":1792491277246,"version":"4.5.0"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"\n Importance<\/jats:title>\n In December 2025, the Advisory Committee on Immunization Practices (ACIP) voted to replace the universal hepatitis B birth-dose recommendation with shared clinical decision-making for infants born to mothers who screen negative for hepatitis B surface antigen. Although the proposal would not alter recommendations for infants of unscreened mothers, historical data suggest that removing a universal birth-dose vaccine recommendation may reduce vaccination coverage in this group.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate the impact of replacing universal hepatitis B virus (HBV) birth-dose vaccination with a targeted recommendation on neonatal and subsequent chronic HBV infections in the US.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A compartmental model and simulated a US birth cohort (n\u2009=\u20093\u202f659\u202f289) under the 2 vaccine recommendations: universal birth-dose vaccination and targeted birth-dose vaccination vaccine recommendations, where the birth dose was recommended to infants of screened-positive or unscreened mothers and shared-decision making is recommended for infants of screened-negative mothers. Parameter values were literature derived and uncertainty was incorporated across 5000 iterations. These data were analyzed from September through November 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Birth-dose vaccine recommendations and birth-dose vaccination coverage among infants of unscreened mothers.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Numbers of neonatal and subsequent chronic HBV infections.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n With the current maternal HBV screening rate of 86%, the universal birth-dose vaccine recommendation resulted in a median of 1292 neonatal infections (95% percentile interval [PI], 670-2228). In comparison, the targeted birth-dose vaccine recommendation was associated with 628 additional neonatal infections (95% PI, 340-1034) when birth-dose vaccination coverage among infants of unscreened mothers was 10% (mirroring historic coverage declines under a targeted recommendation) and 69 additional infections (95% PI, \u221232 to 190) when coverage was 80% (mirroring levels under a universal recommendation.) To offset the excess infections under the targeted birth-dose vaccine recommendation, more than 100\u202f000 additional pregnant individuals would need to be screened if the birth-dose vaccination coverage among infants of unscreened mothers was 80%, and more than 400\u202f000 if coverage was 10%.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Findings from this study indicate that the targeted birth-dose vaccine recommendation will likely increase neonatal infections unless maternal screening rises substantially or vaccination coverage among infants of unscreened mothers exceeds current levels. As historic data show such improvements are unlikely, these findings underscore the continued importance of universal screening and vaccination as complementary safeguards.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2026.1226","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:30:48Z","timestamp":1777303848000},"page":"891","source":"Crossref","is-referenced-by-count":6,"title":["Impact of Removing the Universal Hepatitis B Birth-Dose Vaccination in the US"],"prefix":"10.1001","volume":"180","author":[{"given":"Margaret L.","family":"Lind","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts"},{"name":"Department of Medicine, Section of Infectious Diseases, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt D. T.","family":"Hitchings","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, College of Public Health & Health Professions, University of Florida, Gainesville"},{"name":"Emerging Pathogens Institute, University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni P.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Diseases, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Linas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Diseases, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek A. T.","family":"Cummings","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Johns Hopkins University, Baltimore, Maryland"},{"name":"Department of Biomedical Engineering, School of Engineering, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Diseases, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"},{"name":"Department of Pediatrics, Section of Infectious Diseases, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"poi260019r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the united states: recommendations of the Advisory Committee on Immunization Practices.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"poi260019r18","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2147\/IJWH.S51138","article-title":"Vertical transmission of hepatitis B virus: challenges and solutions.","volume":"6","author":"Gentile","year":"2014","journal-title":"Int J Womens Health"},{"key":"poi260019r19","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/S0264-410X(99)00457-0","article-title":"Clinical course and consequences of hepatitis B infection.","volume":"18","author":"Juszczyk","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"poi260019r20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12325-022-02284-1","article-title":"Characteristics, treatment patterns, and clinical outcomes of chronic hepatitis B across 3 continents: retrospective database study.","volume":"40","author":"Gillespie","year":"2023","journal-title":"Adv Ther"},{"issue":"35","key":"poi260019r21","first-page":"780","article-title":"Availability of hepatitis B vaccine that does not contain thimerosal as a preservative.","volume":"48","author":"US Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6 Pt 1","key":"poi260019r22","doi-asserted-by":"publisher","first-page":"e645","DOI":"10.1542\/peds.111.6.e645","article-title":"Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.","volume":"111","author":"Biroscak","year":"2003","journal-title":"Pediatrics"},{"issue":"7","key":"poi260019r24","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1097\/INF.0000000000001516","article-title":"Hepatitis B surface antigen testing among pregnant women, United States 2014.","volume":"36","author":"Kolasa","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"poi260019r25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.amepre.2023.01.041","article-title":"Gaps in prenatal hepatitis B screening and management of HBsAg positive pregnant persons in the US, 2015-2020.","volume":"65","author":"Pham","year":"2023","journal-title":"Am J Prev Med"},{"issue":"3","key":"poi260019r28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-1823","article-title":"National perinatal hepatitis B prevention program: 2009-2017.","volume":"147","author":"Koneru","year":"2021","journal-title":"Pediatrics"},{"issue":"4","key":"poi260019r31","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2023.12.023","article-title":"Society for Maternal-Fetal Medicine Consult Series #69: hepatitis B in pregnancy: updated guidelines.","volume":"230","author":"Badell","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"poi260019r32","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/hep.31991","article-title":"Prevalence of HBV infection, vaccine-induced immunity, and susceptibility among at-risk populations: US households, 2013-2018.","volume":"74","author":"Roberts","year":"2021","journal-title":"Hepatology"},{"issue":"8","key":"poi260019r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101064","article-title":"Proportion of pregnant women with HBV infection eligible for antiviral prophylaxis to prevent vertical transmission: a systematic review and meta-analysis.","volume":"6","author":"Delamare","year":"2024","journal-title":"JHEP Rep"},{"issue":"4","key":"poi260019r34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1001\/jama.2019.9365","article-title":"Screening for hepatitis B virus infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement.","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"poi260019r35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12876-018-0847-2","article-title":"Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies from other countries.","volume":"18","author":"Li","year":"2018","journal-title":"BMC Gastroenterol"},{"issue":"7537","key":"poi260019r36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/bmj.38719.435833.7C","article-title":"Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis.","volume":"332","author":"Lee","year":"2006","journal-title":"BMJ"},{"issue":"8359","key":"poi260019r37","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.","volume":"2","author":"Beasley","year":"1983","journal-title":"Lancet"},{"issue":"4","key":"poi260019r38","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx225","article-title":"Comparative effectiveness of prophylactic strategies for perinatal transmission of hepatitis B virus: a network meta-analysis of randomized controlled trials.","volume":"4","author":"Chen","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"poi260019r39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/INF.0000000000001953","article-title":"Hospital, maternal and birth factors associated with hepatitis B vaccination at birth: West Virginia, 2015.","volume":"37","author":"Massey","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"38","key":"poi260019r40","doi-asserted-by":"publisher","first-page":"844","DOI":"10.15585\/mmwr.mm7338a3","article-title":"Decline in vaccination coverage by age 24 months and vaccination inequities among children born in 2020 and 2021\u2014National Immunization Survey-Child, United States, 2021-2023.","volume":"73","author":"Hill","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"poi260019r41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/cid\/ciz841","article-title":"Trends in hepatitis B infection and immunity among women of childbearing age in the United States.","volume":"71","author":"Kushner","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"40","key":"poi260019r42","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.15585\/mmwr.mm6740a4","article-title":"Vaccination coverage among children aged 19-35 months\u2014United States, 2017.","volume":"67","author":"Hill","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"poi260019r43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1186\/1471-2458-10-710","article-title":"Validation of population-based disease simulation models: a review of concepts and methods.","volume":"10","author":"Kopec","year":"2010","journal-title":"BMC Public Health"},{"issue":"3","key":"poi260019r44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I","article-title":"Hepatitis B: an important public health issue.","volume":"61","author":"Maddrey","year":"2000","journal-title":"J Med Virol"},{"issue":"3","key":"poi260019r45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cld.2019.04.008","article-title":"WHO guidelines for prevention, care and treatment of individuals infected with HBV: a US perspective.","volume":"23","author":"Vittal","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"Suppl 1","key":"poi260019r46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma.","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"poi260019r48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/cid\/ciab405","article-title":"Cost-effectiveness of 1-time universal screening for chronic hepatitis B infection in adults in the United States.","volume":"74","author":"Toy","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"poi260019r50","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.amepre.2019.05.005","article-title":"Hepatitis B birth dose: first shot at timely early childhood vaccination.","volume":"57","author":"Oster","year":"2019","journal-title":"Am J Prev Med"},{"key":"poi260019r53","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.12735","article-title":"Racial\/ethnic disparities in the prevalence and awareness of hepatitis B virus infection and immunity in the United States.","author":"Kim","year":"2017","journal-title":"J Viral Hepat"},{"issue":"1","key":"poi260019r55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s12913-022-07813-w","article-title":"Exploring factors associated with hepatitis B screening in a multilingual and diverse population.","volume":"22","author":"Chu","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"poi260019r2","unstructured":"US Centers for Disease Control and Prevention. ACIP recommends individual-based decision-making for hepatitis B vaccine for infants born to women who test negative for the virus. Accessed March 23, 2026. https:\/\/www.cdc.gov\/media\/releases\/2025\/2025-acip-recommends-individual-based-decision-making-for-hepatitis-b-vaccine-for-infants-born-to-women.html"},{"key":"poi260019r3","unstructured":"US Centers for Disease Control and Prevention. Next ACIP meeting: anticipated votes. Accessed March 23, 2026. https:\/\/www.cdc.gov\/acip\/meetings\/upcoming.html"},{"key":"poi260019r4","unstructured":"Huang? P. CDC advisers vote to overturn decades-long policy on hepatitis B vaccine for infants. Accessed March 23, 2026. https:\/\/www.npr.org\/sections\/shots-health-news\/2025\/12\/05\/nx-s1-5634004\/cdc-hepatitis-b-vaccine-acip-meeting"},{"key":"poi260019r5","unstructured":"Nevison? C. Burden of disease. Accessed March 23, 2026. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-12-04-05\/02-nevison-Hepatitis-B-508.pdf"},{"key":"poi260019r6","unstructured":"Pebsworth? V. Hepatitis B virus vaccine birth dose. Accessed March 23, 2026. https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-12-04-05\/01-Pebsworth-hepatitis-b-508.pdf"},{"key":"poi260019r7","unstructured":"US Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. Accessed March 23, 2026. https:\/\/www.youtube.com\/live\/kUgXRUpKal4"},{"key":"poi260019r8","unstructured":"Kansagra? S, Baker-White? A, Martin? K, Baggett? J. Implications of ACIP vote on Hepatitis B vaccine for newborns. Accessed March 23, 2026. https:\/\/www.astho.org\/communications\/blog\/2025\/outcomes-implications-of-acip-vote-on-hepatitis-b-vaccine-for-newborns\/"},{"key":"poi260019r9","unstructured":"Northeast Public Health Collaborative. Recommendations statement on hepatitis B and newborns. Accessed March 23, 2026. https:\/\/www.nyc.gov\/assets\/doh\/downloads\/pdf\/press\/2025\/11212025-nephc-hep-B-newborn-dose-statement.pdf"},{"key":"poi260019r10","unstructured":"California Department of Public Health. The West Coast Health Alliance, CDPH, and leading national medical organizations continue to recommend hepatitis B vaccination for newborns. Accessed March 23, 2026. https:\/\/www.cdph.ca.gov\/Programs\/OPA\/Pages\/NR25-022.aspx"},{"key":"poi260019r11","unstructured":"Arizona Department of Health Services. Newborns receive hepatitis B vaccine at birth for good reason. Accessed March 23, 2026. https:\/\/directorsblog.health.azdhs.gov\/newborns-receive-hepatitis-b-vaccine-at-birth-for-good-reason\/"},{"key":"poi260019r12","unstructured":"Colorado Department of Public Health & Environment. Colorado recommends continued universal hepatitis B vaccination for newborns. Accessed March 23, 2026. https:\/\/cdphe.colorado.gov\/press-release\/continued-universal-hepatitis-b-vaccination-for-newborns"},{"key":"poi260019r13","unstructured":"Illinois Department of Public Health. IDPH Statement on ACIP Action Regarding Hepatitis B Vaccine. Accessed March 23, 2026. https:\/\/dph.illinois.gov\/resource-center\/news\/2025\/december\/release-20251205.html"},{"key":"poi260019r14","unstructured":"State of Michigan Department of Health and Human Services. MDHHS issues statement on hepatitis B vaccine. Accessed March 23, 2026. https:\/\/content.govdelivery.com\/attachments\/MIDHHS\/2025\/12\/05\/file_attachments\/3484594\/Hep%20B%20statement.pdf"},{"key":"poi260019r15","unstructured":"New Mexico Department of Health. Department of Health recommends hepatitis B vaccine. Accessed March 23, 2026. https:\/\/www.nmhealth.org\/news\/awareness\/2025\/12\/?view=2304"},{"key":"poi260019r16","unstructured":"Vermont Department of Health. Vermont Department of Health supports science-based recommendations for hepatitis B vaccine. Accessed March 23, 2026. https:\/\/www.healthvermont.gov\/media\/current-news-releases\/vermont-department-health-supports-science-based-recommendations"},{"key":"poi260019r17","unstructured":"US Centers for Disease Control and Prevention. Clinical overview of perinatal hepatitis B. Accessed March 23, 2026. https:\/\/www.cdc.gov\/hepatitis-b\/hcp\/perinatal-provider-overview\/index.html"},{"key":"poi260019r23","unstructured":"Martin? J, Osterman? M. Changes in prenatal care utilization: United States, 2019-2021. Accessed March 23, 2026. https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr72\/nvsr72-04.pdf"},{"key":"poi260019r26","doi-asserted-by":"crossref","unstructured":"Osterman? M, Hamilton? B, Martin? J, Driscoll? A, Valenzuela? C. Births: final data for 2023. Accessed March 23, 2026. https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr74\/nvsr74-1.pdf","DOI":"10.15620\/cdc\/252440"},{"key":"poi260019r27","unstructured":"National Center for Health Statistics. Expected births 2021. Accessed April 3, 2026. https:\/\/www.cdc.gov\/nchs\/data\/vsrr\/vsrr020.pdf"},{"key":"poi260019r29","unstructured":"Corcorran? M, Kim? N. Preventing HBV perinatal transmission. Accessed March 23, 2026. https:\/\/www.hepatitisb.uw.edu\/go\/prevention-hbv\/preventing-perinatal-transmission-hbv\/core-concept\/all"},{"key":"poi260019r30","unstructured":"US Centers for Disease Control and Prevention. Hepatitis B perinatal vaccine information. Accessed March 23, 2026. https:\/\/www.cdc.gov\/hepatitis-b\/hcp\/perinatal-provider-overview\/vaccine-administration.html"},{"key":"poi260019r47","unstructured":"Childrens Hospital of Philadelphia . News & Views\u2014hepatitis B: fast facts for healthcare providers. Accessed March 23, 2026. https:\/\/www.chop.edu\/vaccine-update-healthcare-professionals\/newsletter\/hepatitis-b-fast-facts-healthcare-providers"},{"key":"poi260019r49","doi-asserted-by":"crossref","unstructured":"Hall? EW, Gounder? P, Bradley? H, Nelson? NP. Economic evaluation of delaying the infant hepatitis B vaccination schedule.? medRxiv. Preprint posted online November 25, 2025:2025.11.24.25340907. doi:10.1101\/2025.11.24.25340907","DOI":"10.1101\/2025.11.24.25340907"},{"key":"poi260019r51","unstructured":"US Centers for Disease Control and Prevention. Measles cases and outbreaks. Accessed March 23, 2026. https:\/\/www.cdc.gov\/measles\/data-research\/index.html"},{"key":"poi260019r52","unstructured":"US Centers for Disease Control and Prevention. Vaccination coverage and exemptions among kindergartners. Accessed March 23, 2026. https:\/\/www.cdc.gov\/schoolvaxview\/data\/index.html"},{"key":"poi260019r54","unstructured":"US Centers for Disease Control and Prevention. 2005-2020 Rates of acute hepatitis B by ethnicity. Accessed March 23, 2026. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2020surveillance\/hepatitis-b\/figure-2.6.htm"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2848161\/jamapediatrics_lind_2026_oi_260019_1784851946.85875.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:01:01Z","timestamp":1785769261000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2848161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2026.1226","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}